HADHA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.085200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.227600E-01
Normal-vs-Stage2
8.326000E-01
Normal-vs-Stage3
3.412400E-01
Normal-vs-Stage4
2.725800E-01
Stage1-vs-Stage2
8.453000E-01
Stage1-vs-Stage3
2.505600E-01
Stage1-vs-Stage4
2.974000E-01
Stage2-vs-Stage3
1.853630E-01
Stage2-vs-Stage4
2.889400E-01
Stage3-vs-Stage4
1.294200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.104200E-01
Normal-vs-AfricanAmerican
3.261600E-01
Normal-vs-Asian
1.731670E-02
Caucasian-vs-AfricanAmerican
2.467400E-01
Caucasian-vs-Asian
1.524730E-03
AfricanAmerican-vs-Asian
9.489900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.903200E-01
Normal-vs-Female
6.966400E-01
Male-vs-Female
4.205400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.905000E-01
Normal-vs-Age(41-60Yrs)
8.138400E-01
Normal-vs-Age(61-80Yrs)
5.539200E-01
Normal-vs-Age(81-100Yrs)
9.040200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.354000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.204200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.596600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.964800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.252800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.871620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.329800E-01
Normal-vs-Daily Drinker
7.964000E-01
Normal-vs-Weekly Drinker
3.320600E-01
Normal-vs-Occasional Drinker
8.840200E-01
Normal-vs-Social Drinker
8.271600E-01
Non Drinker-vs-Daily Drinker
3.709600E-01
Non Drinker-vs-Weekly Drinker
8.214400E-01
Non Drinker-vs-Occasional Drinker
9.183700E-02
Non Drinker-vs-Social Drinker
2.735400E-01
Daily Drinker-vs-Weekly Drinker
3.584000E-01
Daily Drinker-vs-Occasional Drinker
4.553600E-01
Daily Drinker-vs-Social Drinker
8.631800E-01
Weekly Drinker-vs-Occasional Drinker
1.203810E-01
Weekly Drinker-vs-Social Drinker
2.313600E-01
Occasional Drinker-vs-Social Drinker
5.603200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.141160E-01
Normal-vs-Grade 2
3.731500E-02
Normal-vs-Grade 3
4.439900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.684300E-02
Grade 1-vs-Grade 3
2.108200E-02
Grade 1-vs-Grade 4
1.141160E-01
Grade 2-vs-Grade 3
5.828600E-01
Grade 2-vs-Grade 4
3.731500E-02
Grade 3-vs-Grade 4
4.439900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.063200E-01
Normal-vs-NonDiabetic
6.920800E-01
Diabetic-vs-NonDiabetic
6.656600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.311000E-01
Normal-vs-NoPancreatitis
7.276400E-01
Pancreatitis-vs-NoPancreatitis
5.922800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.036400E-01
Normal-vs-N1
8.501000E-01
N0-vs-N1
8.230200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.319400E-01
Normal-vs-TP53-NonMutant
5.907200E-01
TP53-Mutant-vs-TP53-NonMutant
6.712800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
